Funding For ‘Holy Grail’ Of Anticoagulant Drugs, University Of Cambridge
XO1 Ltd, a University of Cambridge and Addenbrooke’s Hospital spin-out company, has raised $11 million in funding to develop a
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓